ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiac Septal Hypertrophy in the Fetus of Diabetic Mother and Its Effect on Postnatal Cardiac Function

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01599026
Recruitment Status : Unknown
Verified May 2012 by heba mohamed, Ain Shams Maternity Hospital.
Recruitment status was:  Enrolling by invitation
First Posted : May 15, 2012
Last Update Posted : May 15, 2012
Sponsor:
Information provided by (Responsible Party):
heba mohamed, Ain Shams Maternity Hospital

Brief Summary:
Good glycemic control is superior to poor glycemic control in reducing risk of interventricular septum thickness among fetuses of diabetic mothers

Condition or disease
Cardiology in Fetus of Diabetic Mother

Detailed Description:
Good glycemic control is superior to poor glycemic control in reducing risk of interventricular septum thickness among fetuses of diabetic mothers specially during third trimester of pregnancy

Study Type : Observational
Estimated Enrollment : 120 participants
Time Perspective: Cross-Sectional
Official Title: Cardiac Septal Hypertrophy in the Fetus of Diabetic Mother and Its Effect on Postnatal Cardiac Function
Study Start Date : April 2012
Estimated Primary Completion Date : February 2013
Estimated Study Completion Date : March 2013



Primary Outcome Measures :
  1. To study interventricular septum thickness in fetus of diabetic mother and correlate it with good glycemic control. [ Time Frame: one year ]
    To study interventricular septum thickness in fetus of diabetic mother and correlate it with good glycemic control during third trimester of pregnancy.


Secondary Outcome Measures :
  1. cardiac function in infant of diabetic mother [ Time Frame: one year ]
    To correlate postnatal cardiac function to interventricular septum thickness to reach cut of value of septum thickness for prenatal prediction of symptomatic cardiomyopathy in infant of diabetic mother.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
diabetic pregnant ladies gestational age more than 35 weeks
Criteria

Inclusion Criteria:

  • singleton pregnancy
  • gestational age 36 weeks

Exclusion Criteria:

  • congenital anomalies
  • obstetric complications
  • medical disorders other than diabetes

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01599026


Locations
Egypt
AinShamsMH
Cairo, Egypt, 44511
Sponsors and Collaborators
Ain Shams Maternity Hospital

Responsible Party: heba mohamed, Cardiac septal hypertrophy in the fetus of diabetic mother and its effect on postnatal cardiac function, Ain Shams Maternity Hospital
ClinicalTrials.gov Identifier: NCT01599026     History of Changes
Other Study ID Numbers: dhvf 7531
First Posted: May 15, 2012    Key Record Dates
Last Update Posted: May 15, 2012
Last Verified: May 2012

Keywords provided by heba mohamed, Ain Shams Maternity Hospital:
cardiology
fetus of diabetic mother

Additional relevant MeSH terms:
Hypertrophy
Pathological Conditions, Anatomical